chartexchange

REVB
Revelation Biosciences, Inc. Common Stock
stockNASDAQ

At CloseOct 16, 2026 3:55:26 PM EDT
0.48USD-37.339%(-0.28)637,093
Pre-marketOct 16, 2026 9:25:30 AM EDT
0.6915USD-9.276%(-0.0707)
After-hoursOct 16, 2026 4:24:30 PM EDT
0.49USD+2.596%(+0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$0.76
Beta
1.76
52-Week High
$5.80 2026-01-23
52-Week Low
$0.47 2026-10-16
SMA 50
$0.94
SMA 200
$1.31
Avg. Vol 10D
98,762
Avg. Vol 30D
52,727
Avg. Vol 90D
46,619
Relative Vol
12.08
3.05M
70.8500%
3,096
Nov 5, 2026 (19d)
Jan 28, 2026 · 1-for-4 (reverse)
REVB Profile

we develop immunologic therapeutics and diagnostics designed to make the world a healthier place

REVB Performance
PeriodPriceDateChangeBeta
1W0.762026-10-09-35.54%17.292
1M0.952026-09-17-48.44%6.322
3M1.182026-07-17-58.49%4.006
6M1.152026-04-17-57.22%1.618
1Y5.162025-10-17-90.51%1.758
2Y163.182024-10-17-99.70%—
5Y1,715,616.002022-01-11-100.00%1.183
REVB Stock Summary

Revelation Biosciences, Inc. Common Stock (NASDAQ:REVB) stock price today is $0.49, and today's volume is 637,093. REVB is down 35.739% today. The 30 day average volume is 52,727. REVB market cap is $1.95M with 3.98M shares outstanding.